Heartbeam Inc (BEAT NASDAQ) stock market data APIs
$1.4104
-0(-0%)
as of September 17, 2025
Try our APIs with
free plan!
Heartbeam Inc Financial Data Overview
Price chart is built with
Anychart
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Prev. Close
1.4104
Open
1.409
High
1.4216
Low
1.3917
52 wk Range
0.9101-3.48
Market Cap
48 379 K
Shares Outstanding
34 312 K
EPS
-0.15
Beta
-0.702
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Heartbeam Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Heartbeam Inc data using free add-ons & libraries
Get Heartbeam Inc Fundamental Data
Heartbeam Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -19 880 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-13
- EPS/Forecast: -0.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Heartbeam Inc News
New
HeartBeam Cuts Costs Awaits FDA Decision
HeartBeam (NASDAQ:BEAT) reported its Q2 2025 results on July 16, 2025, reaffirming key regulatory and commercial milestones and announcing a 23% sequential decrease in cash burn to $3.4 million. The c...
HeartBeam (BEAT) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, August 13, 2025 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Rob Eno Chief Financial Officer — Tim Cruickshank Vice President, I...
HeartBeam Inc (NASDAQ:BEAT) Reports Q2 2025 Results: Narrower Loss, FDA Progress, and Mixed Market Reaction
HeartBeam Inc (NASDAQ:BEAT [https://www.chartmill.com/stock/quote/BEAT]) reported its second-quarter 2025 financial results, posting a net loss of $5.0 million, or $(0.15) per share, compared to a net...
HeartBeam GAAP EPS of -$0.15 beats by $0.03
* HeartBeam press release [https://seekingalpha.com/pr/20200126-heartbeam-reports-second-quarter-2025-results] (NASDAQ:BEAT [https://seekingalpha.com/symbol/BEAT]): Q2 GAAP EPS of -$0.15 beats by $0...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
